$AVO

Gonzalez Luis A sold $2.7M of AVO (indirect holdings)

Gonzalez Luis A sold 201,176 indirectly-held shares of Mission Produce, Inc. (AVO) at an average of $13.46 ($13.32–$13.53, $2.71M total) across 3 trades over 2024-09-18 to 2024-09-20.

Original reporting
SEC EDGAR · Gonzalez Luis A
Published Aug 4, 2026, 4:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 6, 2026, 6:19 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AVO
Neutral
medium confidence
Mentioned
$AVO
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AVONeutralLow
01

Why it matters

This is a disclosed open-market sale totaling about $2.71M, with no pre-arranged 10b5-1 plan stated. The filing itself does not include any new operational or financial guidance.

02

Market read

Traders may note insider selling as a sentiment input, but the disclosure lacks fundamental catalysts and the sale dates are in 2024.

03

What to watch

The trades occurred in September 2024, so the market reaction in 2026 is more about disclosure timing than new information about current fundamentals.

Relevance 6/10Novelty 3/10Timing: filed 2026-08-04 for trades dated 2024-09-18 to 2024-09-20

Background

The article summarizes an SEC Form 4 insider transaction for Mission Produce, Inc. (AVO) by Gonzalez Luis A, a director and 10% owner, with indirect holdings.

Company-level read

Ticker impact

$AVONeutralMedium confidence
Context

Mission Produce Form 4 shows director/10% owner Gonzalez Luis A sold $2.71M of AVO via indirect open-market sales across three trades.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven and typically fades unless repeated or paired with other disclosures.

Evidence & confidence

Form 4 insider sales are common and often non-informational; the article provides transaction size and timing but no earnings, guidance, or operational change.

Market effects

No sector-level implications; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

The sale may be liquidity or diversification-driven and not a bearish signal, especially since the filing does not cite any negative company development.

Key entities

  • Mission Produce, Inc.

    AVO, the company whose insider transaction is disclosed on Form 4.

  • Gonzalez Luis A

    Director and 10% owner who sold shares via indirect holdings.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AVOMed

Why Mission Produce (AVO) Shares Are Plunging Today

Mission Produce (AVO) shares fell 11.3% after setting 5-year targets: mid-single-digit sales growth, 300 bps margin expansion, and 2035 goals to double sales and triple EBITDA. The company raised Calavo synergy targets to over $30M. Q3 revenue was $450M, up 25.8% YoY, beating estimates. Adjusted EPS was $0.18, a 56.5% beat. Stock is down 4.1% YTD, 27.6% off 52-week high.

$AVOMed

Mission Produce Unveils Five-Year Financial Targets and Strategies at 2026 Investor Day

Mission Produce (AVO) hosted its 2026 Investor Day, outlining five-year targets: mid-single-digit organic sales growth, 300 basis points of margin expansion, and 90% cash conversion. The company aims to double sales and triple Adjusted EBITDA by 2035, supported by Calavo integration, Prepared Foods expansion, and asset utilization. Management expects high-single-digit to double-digit annual shareholder returns.

$AVOMed

Mission Produce unveils five-year targets, $100M buyback, aims to double sales and triple EBITDA by 2035

Mission Produce announced a five-year plan with mid-single-digit organic sales growth, 300bps margin expansion, and 2035 targets to double sales to $4B and triple Adjusted EBITDA to $450M. The company reaffirmed fiscal 2H26 Adjusted EBITDA outlook of $84–88M and Q426 Adjusted EBITDA of $52–55M. It also launched a $100M share repurchase program, with 290,994 shares repurchased at an average price of $12.94.

$AVOMedAI 8/10

Acquisition Momentum Offset by Profitability Headwinds for Mission Produce (AVO)

Mission Produce (AVO) reported Q3 FY26 adjusted EBITDA of $32.4M, beating expectations. Revenue rose 26% YoY to $450M, driven by avocado supply growth and the Calavo acquisition. However, profitability declined, with adjusted net income down YoY. Q4 adjusted EBITDA is projected at $52M-$55M, incorporating Calavo benefits. Institutional investment remained steady, with 20 hedge funds holding shares.